DePuy Mitek BIOKNOTLESS Plus w/ OC-Indicated for use in soft tissue to bone fixation in…
Recall Z-1679-2023, part of FDA recall event 92210. See DePuy Mitek, Inc., a Johnson & Johnson's company page.
DePuy Mitek, Inc., a Johnson & Johnson Co. started this Class II device recall on Apr 13, 2023 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Apr 13, 2023
- Status: Ongoing
- Products in this event: 5
IFU Warning: Applying bending force and/or bending force with impaction to the BIOKNOTLESS¿ Anchor Inserter may cause a fragment of the inserter tip to break off during use and be retained in the patient. broken BIOKNOTLESS¿ Anchor inserter tip detected during surgery may require removal, potentially causing bone damage and longer surgery time
- Product
- DePuy Mitek BIOKNOTLESS Plus w/ OC-Indicated for use in soft tissue to bone fixation in association with adequate postoperative immobilization Model Number: 212726
- Quantity
- 2372 units
- Lots and codes
- UDI-DI: 10886705002122 All lot numbers
- Distribution
- Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Canada, Switzerland, China, Czech Republic, Germany, Egypt, Spain, United Kingdom, Hong Kong, Hungary, Ireland, India, Italy, Korea, Netherlands, New Zealand, Slovakia, Thailand.
- Recalling firm
- DePuy Mitek, Inc., a Johnson & Johnson Co., Norwood, MA, United States
- How the firm notified
- Letter
- FDA classified
- Jun 2, 2023
- DePuy Mitek BIOKNOTLESS Plus w/ Panacryl-Indicated for use in soft tissue to bone fixation in association with adequate…Z-1678-2023 · Class II · Apr 13, 2023 · Ongoing
- DePuy Mitek BIOKNOTLESS Rapid W/ OC-Indicated for use in soft tissue to bone fixation in association with adequate…Z-1680-2023 · Class II · Apr 13, 2023 · Ongoing
- DePuy Mitek BIOKNOTLESS Plus w/ Ethibond-Iindicated for use in soft tissue to bone fixation in association with…Z-1677-2023 · Class II · Apr 13, 2023 · Ongoing
- DePuy Mitek BIOKNOTLESS Rapid w/ Pan-Indicated for use in soft tissue to bone fixation in association with adequate…Z-1681-2023 · Class II · Apr 13, 2023 · Ongoing
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports